Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chondroitin sulfate proteoglycan 4 pseudogene 10 (CSPG4P10)
- Target
- CSPG4P10
- Molecular classification
- Processed pseudogene, Long noncoding RNA (lncRNA)
01
Overview
Chondroitin sulfate proteoglycan 4 pseudogene 10 (CSPG4P10) is a processed pseudogene genomically related to the protein-coding gene CSPG4, which is also known as neuron-glial antigen 2 and is highly expressed in various cancers[1]. CSPG4P10 does not encode a functional protein but may be transcribed into noncoding RNA. Pseudogenes like CSPG4P10 can regulate their parental genes by acting as competing endogenous RNAs, influencing cell proliferation, migration, and cancer-related pathways. There is extensive evidence that some CSPG4-derived pseudogenes (e.g., CSPG4P12) can act as tumor suppressors or oncogenes by modulating microRNA activity[1][2]. There is no direct evidence or peer-reviewed research describing the biological function, disease relevance, or druggability of CSPG4P10 itself.
- Other names
- CSPG4P10
02
Mechanism of action
None known
03
Biological functions
Competing endogenous RNA (ceRNA) activity is possible, similar to other CSPG4 pseudogenesPotential post-transcriptional regulation of parental CSPG4 geneModulation of microRNA availabilityOther regulatory RNA functions such as microRNA sponge
04
Disease associations
Potential regulator in cancer progression (based on parent gene information, but no direct evidence for CSPG4P10)
Beyond the preview
Go deeper on Chondroitin sulfate proteoglycan 4 pseudogene 10 (CSPG4P10).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chondroitin sulfate proteoglycan 4 pseudogene 10 (CSPG4P10).